Wilmington, DE, United States of America

Mark Scott Payne

This inventor holds 177 USPTO granted patents and 23 published patent applications, plus 10 CIPO patents and 35 EPO patents, primarily in Glucosyltransferase Engineering (CPC class C08B37-0009). Top assignees: E.i. Dupont De Nemours and Company, Colgate Palmolive Company, Nutrition & Biosciences USA 4, Inc.. Active years: 1994-2025.

USPTO Granted Patents = 177 

% Patents Active = 66.1

 

 

Average Co-Inventor Count = 4.0

ph-index = 21

Forward Citations = 1,687(Granted Patents)

Forward Citations (Not Self Cited) = 1,131(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Lake Worth, FL (US) (1994 - 1995)
  • Wilmiington, DE (US) (2006)
  • Neenah, WI (US) (2010 - 2017)
  • Houston, TX (US) (2004 - 2023)
  • Wilmington, DE (US) (1997 - 2024)

Company Filing History:


Years Active: 1994-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Glucosyltransferases
Oral Care
Enzymatic Synthesis
Glucan Polymers
Whitening Compositions
Well Fracturing
Laundry Care
Electrical Motors
Stability Methods
Fructose Syrup
Additive Units
Poly Alpha-1,3-Glucan
177 patents (USPTO):Explore Patents

Title: Mark Scott Payne: Innovating Oral Care with 159 Patents

Introduction:

Meet Mark Scott Payne, an accomplished inventor hailing from Wilmington, DE (US). With an impressive portfolio of 159 patents, Payne has made significant contributions to the field of oral care compositions and whitening systems. This article delves into his latest patents, career highlights, collaborations, and the impact of his innovations on the industry.

Latest Patents:

Among Payne's recent patents, two standout oral care compositions deserve special mention. The first patent involves an oral care composition designed to stabilize catalyzing enzymes. This innovative blend incorporates a variety of ingredients, including a source of hydrogen peroxide, an acyl donor, a non-aqueous anhydrous liquid, and a surfactant mixture comprising sodium lauryl sulfate (SLS), Betaine, and a poloxamer.

In his second patent, Payne developed a whitening system based on a two-part oral care kit. The first reservoir in the kit contains a whitening reagent, including triacetin, while the second reservoir offers a catalytic enzyme and a second whitening reagent comprising a peroxide forming compound. This system provides an effective and accessible whitening solution for oral care enthusiasts.

Career Highlights:

Throughout his career, Mark Scott Payne has worked with renowned companies, such as E.I. du Pont de Nemours and Company, known as DuPont, and Colgate Palmolive Company. These high-profile collaborations have not only allowed Payne to widen his industry knowledge but also fueled innovative breakthroughs in oral care.

Payne's expertise in oral care compositions and whitening systems has earned him recognition as a leading inventor in this domain. His patented inventions have paved the way for safer, more effective, and accessible oral care products, ultimately improving people's oral health and enhancing their smiles.

Collaborations:

Collaborations play an integral role in the innovation ecosystem, and Mark Scott Payne has had the privilege of working alongside talented individuals in his field. Among his notable coworkers are Robert DiCosimo and John Edward Gavagan. These collaborative efforts have fostered knowledge exchange and propelled the development of groundbreaking solutions within the oral care industry.

Conclusion:

Mark Scott Payne's contributions to the field of oral care compositions and whitening systems have revolutionized the way we approach oral health. With an impressive array of 159 patents, Payne has demonstrated his expertise in formulating oral care products that are both effective and safe. Collaborating with reputable companies and industry professionals has further bolstered his contributions. As we move forward, Payne's innovations will continue to shape the oral care landscape, keeping smiles brighter and healthier for generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…